Altium Capital Management LP Cara Therapeutics, Inc. Transaction History

Altium Capital Management LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$8.88 - $12.77 $26,284 - $37,799	2,960 Added 1.53%	195,960 $2.1 Million
Q3 2022 Nov 14, 2022	SELL	$8.24 - $12.56 $1.32 Million - $2.01 Million	-160,200 Reduced 45.36%	193,000 $1.81 Million
Q2 2022 Aug 15, 2022	BUY	$7.45 - $13.84 $1.4 Million - $2.6 Million	188,200 Added 114.06%	353,200 $3.23 Million
Q1 2022 May 16, 2022	BUY	$9.94 - $12.65 $1.64 Million - $2.09 Million	165,000 New	165,000 $2.01 Million
Q3 2021 Nov 15, 2021	SELL	$11.55 - $16.06 $1.73 Million - $2.41 Million	-150,000 Closed	0 $0

Q2 2021 Aug 13, 2021	BUY	$12.38 - $29.19 $1.86 Million - $4.38 Million	150,000 New	150,000 $2.14 Million

102

21.5M

50K

Ticker CARA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 53,725,900
Market Cap $14M
Description
Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.